Adaptive Biotechnologies

ADPT • NASDAQ • Stock Fundamentals

Adaptive Biotechnologies is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Chad Robins, with a market cap of $3.0B.

Market Cap$3.0B

Employees709.0

CEOChad Robins

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026

Next EarningsAug 4, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Adaptive Biotechnologies

Adaptive Biotechnologies (ADPT) has a market capitalization of $3.0B and trades on NASDAQ.

Adaptive Biotechnologies has approximately 709 employees.